World-class expertise for your drug candidates
Medelis' medical founders, team physicians and clinical trial management physicians are internationally-recognized oncology thought leaders. They organize and chair sessions at national and international oncology meetings and serve as officers and board members of professional oncology organizations, including The American Association for Cancer Research and The American Society of Clinical Oncology.
Medical Expert Team
Daniel D. Von Hoff, M.D., F.A.C.P.
Daniel D. Von Hoff, M.D. is currently Senior Investigator and Head of Translational Research at the Translational Genomics Research Institute's (TGen) Translational Drug Development Division and Head, Pancreatic Cancer Research Program in Phoenix, Arizona. He also serves as Chief Scientific Officer for US Oncology and the Scottsdale Clinical Research Institute. More ...
Michael S. Gordon, M.D.
Dr. Michael Gordon serves as President and CEO of Premiere Oncology of Arizona, Associate Director of Clinical Research for the Arizona Cancer Center and as Associate Professor of Clinical Medicine at the University of Arizona College of Medicine. More ...
James T. Gourzis, M.D., Ph.D.
James T. Gourzis, M.D., Ph.D. has more than 30 years of experience in designing and leading clinical trials, implementing regulatory strategies, and negotiating licensing transactions. More ...
Sujuan Ba, Ph.D.
Sujuan Ba, Ph.D. is the Chief Operating Officer and Chief Scientific Officer for the National Foundation for Cancer Research. More ...
Alan Sandler, M.D.
Alan Sandler, M.D. is a Professor of Medicine at Oregon Health & Science University. Board-certified in Medical Oncology and Internal Medicine, he specializes in cancer and blood disorders with a sub-specialty in lung cancer. More ...
James Cassidy, MBChB, MD, MSc, FRCP
James Cassidy, MBChB, MD, MSc, FRCP is a Professor of Oncology and heads the Medical Oncology Department and the Division of Cancer Sciences & Molecular Pathology at the University of Glasgow, Scotland. More ...
Management
Robert T. Bosserman, J.D. - President, CEO & Chairman
Bob Bosserman has more than 30 years of experience in senior management of both large and small companies in high-technology industries, from computers to water purification to software to biotechnology. Bob was a principal founder of Medelis in 2003 and has led the company as CEO since early 2006. More ...
E. Laughlin (Larry) Flanagan - Founder, Director
Larry Flanagan has a 25+ year history of senior management and finance/operations roles. Most recently, Larry was President and CEO of Keneisys Corp, a small security software company. More ...
David Browning - Vice President, Clinical Operations
David Browning has over 14 years of clinical research experience, which includes extensive CRO experience leading Phase I - III clinical studies in the US. More ...
Dr. Deirdre Tessman - Managing Director, Medelis Europe
Dr. Deirdre Tessman has more than 30 years of worldwide drug development and regulatory experience. She has directed all phases of pharmaceutical development from research through drug approval and marketing with additional expertise in the startup and turnaround of pharmaceutical companies. More ...
Dr. Joseph Sinkule - Vice President, Regulatory Affairs
Dr. Joseph Sinkule has over 27 years of pharmaceutical and biotechnology management experience in the research, development, manufacturing and commercialization of drugs, medical devices, and biologics. More ...
Dr. Mike McGarry - Vice President, Preclinical Studies
Dr. Mike McGarry is a preclinical research scientist with over 35 years of experience generating high quality animal-based data. More ...
Dr. Inder Makin - Vice President, Devices & Radiological Health
Dr. Inder Makin has more than 20 years of experience developing healthcare technologies including medical devices, ultrasound, radio frequency, lasers, magnetic resonance and computer tomography. More ...
Strategic Advisory Board
Michael A. Lechter
Michael A. Lechter, Esq. is a practicing attorney and the author of Protecting Your #1 Asset, Creating Fortunes from Your Ideas, An Intellectual Property Handbook (Warner Books, 2001) and OPM, Other People's Money (Warner Books, 2005), both part of the Rich Dad's Advisors series. More ...
Partners
To deploy exactly the right skills for your trial, Medelis routinely partners with a carefully selected team of other organizations. Our partners include:
Most people with cancer are not aware that taking part in a clinical trial is an option. ClinWorks, Inc. is committed to raising awareness of clinical trials as vital treatment options and to bringing promising clinical trials to patients. The company was started with the idea that the effective and efficient conduct of clinical trials enables new, improved therapies to reach patients sooner. Headquartered in Charlotte, North Carolina, ClinWorks specializes in coordinating all aspects of oncology clinical trials.
Founded in 1973, the National Foundation for Cancer Research (NFCR) supports the work of proven scientists with the funding to accelerate research into the prevention, diagnosis and treatment of cancer. Cumulatively, the organization has provided more than $200 million to support discovery-oriented research, and remains determined to assist in the exploration of previously uncharted territories for potential anticancer agents. NFCR and Medelis have joined forces to take advantage of NFCR's strong international ties to open U.S.-style clinical research organizations in India, China and elsewhere in Asia. These new organizations will offer pharmaceutical and biotechnology companies access to clinical research services with lower cost structures and dramatically improved access to largely untapped patient populations.
Premiere Oncology is a center of excellence dedicated to treating cancer by providing comprehensive and holistic clinical care, with special attention to issues of survivorship and longevity. The aim of the research program is to offer the hopes and benefits of cutting-edge treatments to patients while generating data of the highest quality. Premiere Oncology is also committed to educating future healthcare leaders in oncology practice and research, and providing community education on cancer prevention and treatment opportunities.
